A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines than they are making in profits. The report shows that, on average for these top companies, ...

To end the TB epidemic, Ukraine has only one recipe – to implement quality people-centered TB care! This statement was made by Andriy Klepikov, Executive Director of the Alliance for Public Health at the press conference to mark World Tuberculosis Day. “Within its pilot projects supported ...

To mark World TB Day, 24 March 2017, the International Journal of Infectious Diseases published a special issue on TB. It highlights the Advances, Challenges and Opportunities in the ‘End TB’ Era through publishing 42 articles by a distinguished global authorship. The series of articles review progress ...

More than a third of HIV patients develop oral conditions from immune systems compromised by the virus and its treatment, according to the National Institutes of Health (NIH) While advances in HIV treatment have dramatically improved patient lifespans and quality of life, nagging side effects remain; ...

Neither the government nor CSOs have taken up the services previously supported by the Global Fund In January 2017, the Ministry of Finance of the Russian Federation rejected a request to allocate $1.2 billion over four years for the response to HIV, citing “a lack of ...

The FDA approved AZT in a record 20 months, a move that remains controversial today. HIV was first reported in 1981, but it wasn’t until six years later—in March 1987—that a drug to fight the virus was approved by the Food and Drug Administration (FDA). On ...

Central Asia and the Russian Federation face a major intra-regional migration flow, home, as it is, to one of the largest labor migration corridors in the world, with hundreds of thousands of migrant workers moving from Central Asian countries to the Russian Federation and to ...

A group of 18 of UNAIDS’ top donors have published a report highlighting UNAIDS’ unique value to the communities it serves and its partners and key stakeholders. The assessment, carried out by the Multilateral Organisation Performance Assessment Network (MOPAN), which was set up to monitor ...

High drug pricing for interferon-free direct acting antiviral regimens (up to US$93 000 per 12 week course) has limited broad implementation in the vast majority of settings, with restrictions based on liver disease stage generally introduced to reduce budget impact. Other restrictions, including those based on ...

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. It publishes translational, epidemiological, clinical, operational, and implementation studies. The April 2017 issue is available here. Source

Patent opposition aims to increase affordable access to hepatitis C drug sofosbuvir for millions Rome/Geneva, 27 March 2017 – The international medical humanitarian organisation Médecins Sans Frontières (MSF) has today filed a patent challenge on the hepatitis C drug sofosbuvir with the European Patent Office (EPO) ...

As EATG and the communities of people living with HIV are getting even more intensively involved in work around pre-exposure prophylaxis, or PrEP, it makes sense to remind ourselves of the results of the FLASH PrEP Study conducted by the French HIV organisation AIDES. While subject ...

On 6th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organized the webinar on TB Diagnostics. Moderator: Evgenia Maron Speakers: Ruth McNerney, University of Cape Town – TB Diagnostics Erika Lessem, Treatment Action Group – Advocating for better TB diagnosis Presentations and documents of the webinar

The International Association of Schools of Social Work (IASSW) and UNAIDS have published a new joint report, Getting to zero: global social work responds to HIV, a collection of stories and articles showing how social workers are central to the AIDS response around the world. Launched ...

CORVALLIS, Ore. – Development and widespread use of a vaccine that’s even partially effective against HIV, along with more progress toward diagnosis and treatment, offer the best hopes for turning the corner on a global pandemic that’s still spiraling out of control, researchers reported today. Even ...

An anti-HIV infection drug has “clear potential” to prevent people catching the virus, a Welsh Government-commissioned report has said. Pre-exposure prophylaxis (PrEP) is not currently available on the Welsh NHS. But a report by an independent HIV expert group said it was “highly effective” when used with ...

Inflammatory mechanisms of innate immunity known to be involved in neurodegeneration in HIV-associated neurocognitive disorders (HAND) can be modulated by agents approved in autoimmune neuroinflammation leading to reduced neurotoxicity. About 50% of HIV infected patients have neurocognitive disorders associated with the infection. Despite being on combined ...

Odessa in Ukraine has become the latest city to sign the Paris Declaration to end the AIDS epidemic in cities. Since the end of 2014, more than 200 cities around the world have signed the Paris Declaration and are addressing the significant disparities in access ...